Figure 6.
Effects of ACSM3 on the growth of ovarian cancer tumor in vivo. A xenograft tumor model was built with OV-90 cells infected with Lv-shRNA1-ACSM3 or A2780 cells infected with Lv-ACSM3. (A, B) The volume of xenograft tumors. (C) The expression of ACSM3 and Integrin β1 was measured by immunohistochemistry. Scale bar represented 50 μm. (D, E) Relative protein expression of p-AKT, AKT, c-Myc, Vimentin, and E-cadherin. Measurement data were expressed as mean ± SD of six independent experiments. **p < 0.01 versus Lv-shRNA-NC; #p < 0.05, ##p < 0.01 versus Lv-Vector.